BHARATEQUITY
Loading…
BSE:STARIMAGIN·Healthcare·Verified

Star Imaging and Path Lab Limited

100.50
+0.50(+0.50%)
Day range₹100.00₹100.90
52-week range₹46.00₹152.00
Mkt Cap
175 Cr
P/E (TTM)
9.09
P/B
1.51
Div Yield
0.00%
Open / Prev
100.00 / 100.00
From 52W High
−33.88%
From 52W Low
+118.48%
Day Range
100.00–100.90
Preview · STARIMAGIN

Preview the depth — unlock the full forensic study.

You're reading the free Overview. The full Landscape study, the Lenses, governance and quality scans unlock with Pro — across 5,000 Indian companies.

Explore Pro · ₹999/mo

Briefing

Star Imaging and Path Lab Limited — the brief

Forensic posture: Clean disclosures. Star Imaging's financial filings show excellent earnings quality (86/100 composite score), clean cash-to-profit alignment, and low bankruptcy risk, though the academic engines note modest headwinds in asset efficiency and some share dilution.

What retail misses·The academic engines reveal that while profitability is genuinely strong, asset turnover and return-on-assets have not improved year-over-year, and there has been share dilution — details that don't appear in earnings headlines but matter for long-term shareholder value.

Strengths noted in disclosures: Earnings quality scores in the excellent band (86/100), with cash flow matching reported profits and low manipulation risk signals. · Altman bankruptcy predictor places the company in the safe zone (score 4.39) on the back of strong profitability and manageable leverage. · Top-decile profitability metrics and financially sound fundamentals across multiple quality models.

Forensic signal

From the company's own filings
Signal dossierSTARIMAGIN
1
Momentum
+0.50%
2
52-Week
51% of range
3
Valuation
P/E 9.1×
4
Yield
0.00%
5
Size
175 Cr

Strong: Valuation · Weak: Yield · Size

51%
52-week position
56%
Day position

Sector comparison

Healthcare